Do archaea and bacteria co-infection have a role in the pathogenesis of chronic chagasic cardiopathy?

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 199-207

  Higuchi, Maria de Lourdes ^a   Kawakami, Joyce ^a   Ikegami, Renata ^a   Clementino, Maysa Beatriz Mandetta ^a   Kawamoto, Flavio M ^a   Reis, Marcia M ^a   Bocchi, Edimar ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Archaea; Chagas disease; Chlamydia pneumoniae; Complement C5b 9; Mycoplasma pneumoniae

Indexed keywords

ARCHAEA; BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDOPHILA PNEUMONIAE; MYCOPLASMA; MYCOPLASMA PNEUMONIAE; TRYPANOSOMA CRUZI;

EID: 69049103384     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900026     Document Type: Article

References (61)

1. Aiello VD, Reis MM, Benvenuti LA, Higuchi ML, Ramires JA, Halperin JA 2002. A possible role for complement in the pathogenesis of chronic chagasic cardiomyopathy. J Pathol 197: 224-229.
2. Andreoli WK, Taniwaki NN, Mortara RA 2006. Survival of Trypanosoma cruzi metacyclic trypomastigotes within Coxiella burnetii vacuoles: differentiation and replication within an acidic milieu. Microbes Infect 8: 172-182.
3. Belay N, Johnson R, Rajagopal BS, de Macario EC, Daniels L 1988. Methanogenic bacteria from human dental plaque. Appl Environ Microbiol 54: 600-603.
4. Belay N, Mukhopadhyay B, Conway de Macario E, Galask R, Daniels L 1990. Methanogenic bacteria in human vaginal samples. J Clin Microbiol 28: 1666-1668.
5. Bellotti G, Bocchi EA, de Moraes AV, Higuchi ML, Barbero-Marcial M, Sosa E, Esteves-Filho A, Kalil R, Weiss R, Jatene A, Pileggi F 1996. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J 131: 301-307.
6. Bellotti G, Bocchi EA, de Moraes AV, Higuchi ML, Barbero-Marcial M, Sosa E, Esteves-Filho A, Kalil R, Weiss R, Jatene A, Pileggi F 1998. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J 135: 550.
7. Blanchard A, Bebear CM 2002. Mycoplasmas of humans. In S Razin, R Herrmann (eds.), Molecular biology and pathogenicity of mycoplasmas, Kluwer Academic/Plenum Publisheres, New York, p. 45-71.
8. Boetius A, Ravenschlag K, Schubert CJ, Rickert D, Widdel F, Gieseke A, Amann R, Jørgensen BB, Witte U, Pfannkuche O 2000. A marine microbial consortium apparently mediating anaerobic oxidation of methane. Nature 407: 623-636.
9. Cannio R, Florentino G, Morana A, Ossi M, Bartolucci S 2000. Oxygen: friend or foe? Archaeal superoxide dismutases in the protection of intra- and extracellular oxidative stress. Front Biosci 5: 768-779.
10. Chimenti C, Del Nonno F, Topino S, Abbate I, Licci S, Paglia MG, Capobianchi MR, Petrosillo N, Frustaci A 2007. Fatal myocardial co-infection by Toxoplasma gondii and Parvovirus B19 in an HIV patient. AIDS 21: 1386-1388.
11. Cortez M, Atayde V, Yoshida N 2006. Host cell invasion mediated by Trypanosoma cruzi surface molecule gp82 is associated with F-actin disassembly and is inhibited by enteroinvasive Escherichia coli. Microbes Infect 8: 1502-1512.
12. Cunha-Neto E, Duranti M, Gruber A, Zingales B, De Messias I, Stolf N, Bellotti G, Patarroyo ME, Pilleggi F, Kalil J 1995. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA 92: 3541-3545.
13. De Diego JL, Katz JM, Marshall P, Bessy G, Manning J, Nussenzweig V, Gonzalez J 2001. The ubiquitina-proteasome pathway plays an essential role in proteolysis during Trypanosoma cruzi remodeling. Biochem 40: 1053-1062.
14. DeLong EF 1992. Archaea in coastal marine environments. Proc Natl Acad Sci USA 89: 5685-5689.
15. Dessì D, Delogu G, Emonte E, Catania MR, Fiori PL, Rappelli P 2005. Long-term survival and intracellular replication of Mycoplasma hominis in Trichomonas vaginalis cells: potential role of the protozoon in transmitting bacterial infection. Infect Immun 73: 1180-1186.
16. Eckburg PB, Lepp PW, Relman DA 2003. Archaea and their potential role in human disease. Infect Immun 71: 591-596.
17. Fan T, Lu H, Hu H, Shi L, Mcclarty GA, Nance DM, Greenberg AH, Zhong G 1998. Inhibition of apoptosis in Chlamydia infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med 187: 487-496.
18. Gao W, Luquetti AO, Pereira MA 2003. Immunological tolerance and its breakdown in Chagas' heart disease: role of parasitokines. Front Biosci 8: E218-227.
19. Gille C, Goede A, Schlöetelburg C, Preiβner R, Kloetzel PM, Göbel UB, Frömmel C 2003. A comprehensive view on proteasomal sequences: implications for the evolution of the proteasomo. J Mol Biol 326: 1437-1448.
20. Gonzalez J, Ramalho-Pinto EJ, Frevert U, Ghiso J, Tomlinson S, Scharfstein J, Corey EJ, Nussenzweig V 1996. Proteasome activity is requires for the stage-specific transformation of a protozoan parasite. J Exp Med 184: 1909-1918.
21. Halperin JA, Taratuska A, Nicholson-Weller A 1993. Terminal complement complex C5b-9 stimulates mitogenesis in 3T3 cell. J Clin Invest 91: 1974-1978.
22. Hansen SK, Rainey PB, Haagensen JA, Molin S 2007. Evolution of species interactions in a biofilm community. Nature 445: 533-536.
23. Higuchi ML, Benvenuti LA, Reis MM, Metzger M 2003a. Pathophysiology of the heart in Chagas' disease: current status and new developments. Cardiovasc Res 60: 96-107.
24. Higuchi ML, Britto T, Reis MM, Barbosa A, Bellotti G, Pereira Barreto AC, Pileggi F 1993a. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc Pathol 2: 101-106.
25. Higuchi ML, Góis JM, Reis MM, Higuchi-Dos-Santos MH, Diament J, Sousa JM, Ramires JA, Oliveira SA 2006a. Co-infection ratios versus inflammation, growth factors and progression of early atheromas. APMIS 114: 338-344.
26. Higuchi ML, Gutierrez PS, Aiello VD, Palomino S, Bocchi E, Kalil J, Bellotti G, Pileggi F 1993b. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 423: 157-160.
27. Higuchi ML, Higuchi-dos-Santos MH, Pierri H, Palomino S, Sambiase NV, Ramires JAF, Wajngarten M 2002. Mycoplasma pneumoniae and Chlamydia pneumoniae in calcified nodules of aortic stenotic valves. Rev Inst Med Trop Sao Paulo 44: 209-212.
28. Higuchi ML, Higuchi-dos-Santos MH, Rogério A, Kawakami JT, Bezerra HG, Canzian M 2006b. A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices Clinics 61:473-478.
29. Higuchi ML, Pierri H, Sesso A, Santos MHH, Timenetski J, Strunz CMC, Fukasawa S, Ramires JAF, Wajngarten M 2006c. C-reactive protein and Mycoplasma pneumoniae antigen morphological particles are positively correlated and increased in the serum of elderly atherosclerotic patients. In LV Clark (ed.), New resesarch on atherosclerosis, Nova Science Publisher Inc, New York, p. 1-17.
30. Higuchi ML, Reis MM, Aiello VD, Benvenutti LA Gutierrez PS, Bellotti G, Pileggi F 1997. Asssociation of an increase in CD8+T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56: 485-489.
31. Higuchi ML, Reis MM, Sambiase NV, Palomino SAP, Castelli JB, Gutierrez PS, Aiello VD, Ramires JA 2003b. Co-infection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol 81: 12-22.
32. Higuchi ML, Sambiase N, Palomino S, Gutierrez P, Demarchi LM, Aiello V, Ramires JÁ 2000. Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques. Braz J Med Biol Res 33: 1023-1026.
33. Horn M, Wagner M 2004. Bacterial endosymbionts of free-living amoebae. J Eukaryot Microbiol 51: 509-514.
34. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy 1993. Am J Trop Med Hyg 48: 348-357.
35. Junglas B, Briegel A, Burghardt T, Walther P, Wirth R, Huber H, Rachel R 2008. Ignicoccus hospitalis and Nanoarchaeum equitans: ultrastructure cell-cell interaction, and 3D reconstruction from serial section of freeze-substituted cells and by electron cryotomography. Arch Microbiol 190: 395-408.
36. Katz JT, Shannon RP 2006. Bacteria and coronary atheroma: more fingerprints but no smoking gun. Circulation 113: 920-922.
37. Krishnan L, Sad S, Patel GB, Sprott GD 2000. Archaeosomes induce long-term CD8+cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+T cell help. J Immun 165: 5177-5185.
38. Kudo Y, Nakajima T, Miyaki T, Oyaizu H 1997. Methanogen flora of paddy soils in Japan. FEMS Microbiol Ecol 22: 39-42.
39. Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA 2004. Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci USA 101: 6176-6181.
40. Lo S-C 1992. Mycoplasmas and AIDS. In J Maniloff, RN Mc Elhaney, LR Finch, JB Baseman (eds.), Mycoplasmas, molecular biology and pathogenesis, Am Soc Microbiol, Washington DC, p. 525-545.
41. Madigan MT, JM Martinko, J Parker 2000. Prokaryotic diversity: the Archaea. In MT Madigan, JM Martinko, J Parker (eds.), Brock biology of microorganisms, Prentice-Hall Inc, Upper Saddle River, p. 546-572.
42. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123.
43. Miller TL, Wolin MJ 1983. Stability of Methanobrevibacter smithii populations in the microbial flora excreted from the human large bowel. Appl Environ Microbiol 45: 317-318.
44. Miller TL, Wolin MJ, de Macario EC, Macario AJ 1982. Isolation of Methanobrevibacter smithii from human feces. Appl Environ Microbiol 43: 227-232.
45. Muller-Eberhard HJ 1988. Molecular organization and function of the complement system. Ann Rev Biochem 57: 321-347.
46. Niculescu F, Badea T, Rus H 1999. Sublytic C5b-9 induces proliferation of human aortic smooth mucles cells: role of mitogen activated protein kinase and phosphatidylinositol 3-kinase. Atherosclerosis 142: 47-56.
47. Niemirowicz G, Parussini F, Aguero F, Cazzulo JJ 2007. Two metallocarboxypeptidases from the protozoan Trypanosoma cruzi belong to the M32 family, found so far only in prokaryotes. Biochem J 401: 399-410.
48. Olivares-Villagómez D, McCurley TL, Vnencak-Jones CL, Correa-Oliveira R, Colley DG, Carter CE 1998. Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue. Am J Trop Med Hyg 59: 563-570.
49. Raghoebarsing AA, Pol A, van de Pas-Schoonen KT, Smolders AJ, Ettwig KF, Rijpstra WI, Schouten S, Damsté JS, Op den Camp HJ, Jetten MS, Strous M 2006. A microbial consortium couples anaerobic methane oxidation to denitrification. Nature 440: 918-921.
50. Reis MM, Higuchi ML, Benvenuti LA, Aiello VD, Gutierrez PS, Belotti G, Pileggi F 1997. An in situ quantitative immunohistochemical study of cytokines and IL-2R+in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 83: 165-172.
51. Sant'Anna C, Parussini F, Lourenço D, de Souza W, Cazzulo JJ, Cunha-e-Silva NL 2008. All Trypanosoma cruzi developmental forms present lysosome-related organelles. Histochem Cell Biol 130: 1187-1198.
52. Schul G, Brehm SD, Dallas S, Adams MW 2003. Whole-genome DNA microarray analysis of a hyperthermophile and na archaeon: Pyrococcus fusiosus grown on carbohidrates or peptides. J Bacteriol 185: 3935-3947.
53. Sharma M, Rudel T 2009. Apoptosis resistance in Chlamydia-infected cells: a fate worse than death? FEMS. Immunol Med Microbiol 55: 154-161.
54. Sharma R, Al Nasser FO, Anker SD 2001. The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failure. Heart Fail Monit 2: 42-47.
55. Simmons WL, Denison AM, Dybvig K 2004. Resistance of Mycoplasma pulmonis to complement lysis is dependent on the number of Vsa tandem repeats: shield hypothesis. Infect Immun 72: 6846-6851.
56. Srinivasan V, Morowitz HJ 2006. Ancient genes in contemporary persistent microbial pathogens. Biol Bull 210: 1-9.
57. Sugamori T, Ishibashi Y, Shimada T, Takabashi N, Sakane T, Ohata S, Kunizawa Y, Inoue S, Nakamura K, Ohta Y, Shimizu H, Katoh H, Oyake N, Murakami Y, Hashimoto M 2002. Increased nitric oxide in proportion to the severity of the heart failure in patients with dilated cardiomyopathy: close correlation of tumor necrosis factor-alphawith systemic and local production of nitric oxide. Circ J 66: 627-632.
58. Van Nerom A, Ducatelle R, Charlier G, Haeseebrouck F 2000. Interaction between turkey monocytes and avian - Chlamydia psittaci - in the presence of Mycoplasma sp.: the importance of nitric oxide. Dev Comp Immunol 24: 417-432.
59. Walder G, Gritsch W, Wiedermann CJ, Pölzl G, Laufer G, Hotzel H, Berndt A, Pankuweit S, Theegarten D, Anhenn O, Oehme A, Dierich MP, Würzner RC 2007. Co-infection with two Chlamydophila species in a case of fulminant myocarditis. Care Med 35: 623-626.
60. Yamada S, Niwa J, Ishigaki S, Takahashi M, Ito T, Sone J, Doyu M, Sobue G 2006. Archaeal proteasomos effectively degrade aggregation-prone proteins and reduce cellular toxicities in mammalian cells. J Biol Chem 281: 23842-2351.
61. Yang J, Hooper WC, Phillips DJ, Talkington DF 2004. Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev 15: 157-168.